GATA2 and pancreatic neoplasm: Levels of MICA/B are also elevated in pancreatic cancer [67] and the inhibition of MICA/B, mediated by constitutive activation of the AMPK-GATA2 axis, may serve as a therapeutic target of pancreatic cancer immune evasion [68].